Fasoracetam is a nootropic compound primarily researched for its potential cognitive, mood-regulating, and neurochemical effects. It belongs to the racetam family and is of interest to neuroscientists due to its ability to interact with multiple neurotransmitter systems. While it was originally developed as a treatment candidate for vascular dementia, research has since expanded to explore its application in treating attention disorders, enhancing memory, and investigating neuroplasticity.

• Cognitive Enhancement Studies
  Fasoracetam is frequently used in controlled settings to study short-term memory improvement, focus, and mental clarity. It shows potential in supporting acetylcholine-dependent cognitive functions, a neurotransmitter essential to learning and recall.

• GABA Receptor Modulation
  One of Fasoracetam’s most unique properties is its effect on GABA-B receptors. This makes it particularly relevant in anxiety reduction studies and research on stress-related neurological disorders.

• ADHD and Neurodevelopmental Research
  Recent clinical studies have examined Fasoracetam’s potential in managing ADHD symptoms by addressing glutamate and GABA imbalances, particularly in genetically linked cases such as mGluR mutation-positive ADHD.

• Neuroplasticity and Synaptic Function
  Research indicates that Fasoracetam may influence long-term potentiation and synaptic growth, making it a candidate for experiments involving neural regeneration and brain adaptability.

• Mood and Depression Models
  Due to its impact on glutamate and GABA systems, Fasoracetam is also being tested for its antidepressant-like properties in animal models, especially in treatment-resistant depression frameworks.

• Neurodegenerative Disease Studies
  Fasoracetam’s neuroprotective aspects are being explored in Alzheimer’s and dementia models. Its ability to potentially prevent or reverse receptor downregulation is a key area of research interest.

Fasoracetam is legal to purchase online for research purposes in most jurisdictions. It is not classified as a controlled substance under international law, which makes it available through chemical research suppliers like RC Plug. However, it is important for researchers to distinguish between legality for research use and personal consumption, which remains unauthorized.

• Unscheduled in Most Countries
  Fasoracetam is not listed on any major international drug control schedules (e.g., UN, DEA, EMCDDA), meaning it is legally sellable and shippable for research purposes.

• Research Use Only Labeling
  RC Plug clearly labels all Fasoracetam products as “Not for human consumption” and “For laboratory use only” to comply with global research chemical standards.

• No Prescription Required
  Since Fasoracetam is not an approved pharmaceutical in most countries, it can be purchased without a prescription for non-consumptive purposes.

• Import Regulations May Vary
  Some regions (such as Australia or certain Asian countries) have stricter customs controls. While we ship globally, it is advised that buyers check local import laws to avoid complications.

• Used in Clinical Trials, Not Medicine
  Although Fasoracetam has been investigated in formal clinical trials, it has not yet received medical approval from regulatory bodies like the FDA or EMA.

• Safe and Transparent Online Purchase
  RC Plug provides all necessary chemical identifiers, packaging standards, and batch documentation to ensure the legality and traceability of your purchase.

Fasoracetam is known for its complex and multi-faceted interaction with the brain’s neurotransmitter systems. It modulates GABA-B, glutamate, and cholinergic signaling pathways, which play a major role in mood regulation, memory formation, and overall cognitive performance. These neurochemical effects are the focus of extensive animal and early human trials.

• GABA-B Receptor Upregulation
  Fasoracetam increases the sensitivity of GABA-B receptors, which is linked to reduced anxiety, enhanced calmness, and potential anticonvulsant effects. This makes it valuable in neuroinhibitory research models.

• Acetylcholine Potentiation
  Studies suggest Fasoracetam enhances cholinergic activity by increasing the release of acetylcholine or upregulating its receptors. This is critical for memory encoding and attentional focus.

• Glutamate Modulation
  It has demonstrated a capacity to normalize the expression of metabotropic glutamate receptors (mGluRs), particularly in individuals with genetic deficiencies. This positions it as a unique compound for excitatory neurotransmission research.

• No Dopamine Surge
  Unlike other cognitive enhancers, Fasoracetam does not significantly elevate dopamine, minimizing addiction or euphoric effects. This makes it a cleaner subject for controlled behavioral trials.

• Neuroprotective Signaling
  Fasoracetam may protect neurons against receptor desensitization and oxidative stress, thus maintaining synaptic function over time. This property is currently being studied in aging and neurodegeneration models.

• Influence on Emotional Regulation
  By interacting with GABA and glutamate, Fasoracetam may reduce excitotoxicity and hyperactivity in certain brain regions, suggesting usefulness in models of depression, PTSD, and bipolar disorder.

While Fasoracetam belongs to the racetam class, it differs structurally and pharmacologically from others like Piracetam, Aniracetam, or Phenylpiracetam. It offers a more balanced, anxiolytic effect profile with minimal stimulation, making it especially interesting for researchers focused on calm cognition and mood stabilization rather than hyperactivity or raw energy enhancement.

• Targeted GABA-B Modulation
  Fasoracetam is the only racetam known to significantly upregulate GABA-B receptors. This contrasts with Piracetam and Aniracetam, which focus mainly on AMPA and cholinergic pathways.

• Non-Stimulatory Profile
  Unlike Phenylpiracetam, which increases physical energy and resistance to cold, Fasoracetam has no stimulant properties. This allows researchers to isolate cognitive changes without confounding motor activity.

• Lower Side Effect Potential
  It shows fewer reports of headaches, irritability, or overstimulation compared to stronger racetams, especially when used within reasonable research concentrations.

• Shorter Half-Life
  Fasoracetam acts quickly and clears relatively fast from the system, which provides researchers with tight experimental windows and reduces accumulation risks.

• Mood-Oriented Mechanisms
  Its glutamate and GABA effects make it more suitable for mood and emotion-related trials rather than strictly memory or learning paradigms.

• Synergy with Choline Sources
  Fasoracetam is often paired with alpha-GPC or citicoline in studies to optimize cholinergic output and minimize depletion, a trait that is useful in comparative racetam protocols.

While Fasoracetam is generally well-tolerated in both animal and limited human studies, some side effects have been documented, particularly at higher concentrations or with prolonged exposure. These effects are usually mild and reversible, but they are important for researchers to monitor when conducting trials.

• Headaches Due to Choline Depletion
  As with most racetams, Fasoracetam may deplete choline stores in the brain, leading to tension headaches. Supplementation with choline is commonly recommended in research models to mitigate this.

• Gastrointestinal Discomfort
  Some subjects report nausea, stomach cramps, or a loss of appetite, especially when Fasoracetam is administered on an empty stomach.

• Mood Flattening or Apathy
  At very high concentrations, some participants in studies have shown signs of emotional dulling, possibly due to excessive GABA-B activation.

• Fatigue or Mental Fog
  A paradoxical response in some cases includes drowsiness or reduced mental clarity, particularly when the compound is taken in high dosages or without proper nutrient balance.

• Irritability or Anxiety (Rare)
  Although designed to reduce anxiety, Fasoracetam can sometimes cause increased nervousness or overstimulation in individuals sensitive to cholinergic agents.

• No Serious Adverse Events Documented
  Thus far, there have been no reports of severe toxicity or long-term damage in animal trials or limited human testing, reinforcing its safety profile when used responsibly.

Proper storage of Fasoracetam is crucial to preserving its chemical integrity and ensuring reliable results in experimental research. Like most nootropics and sensitive research chemicals, Fasoracetam can degrade over time if exposed to heat, humidity, or direct light. Following optimal storage protocols not only extends shelf life but also safeguards the consistency of your data.

• Store in a Cool, Dry Environment
  Fasoracetam should be stored at controlled room temperature (ideally 20–25°C or 68–77°F). Excessive heat may accelerate degradation and reduce efficacy in testing environments.

• Keep Away from Light
  UV exposure can break down the molecular structure of Fasoracetam, making lightproof storage essential. Always use opaque containers or store in a dark cabinet.

• Seal in Airtight Containers
  Oxygen and moisture are common culprits in the deterioration of nootropic compounds. Use airtight glass jars or vacuum-sealed pouches to prevent contamination from air exposure.

• Avoid Refrigeration Unless Necessary
  While refrigeration can extend longevity in humid climates, condensation can cause clumping or spoilage if the compound is not properly sealed. Only refrigerate if temperatures exceed recommended ambient conditions.

• Label Clearly
  Proper chemical labeling helps avoid mix-ups in shared lab environments. Include the compound name, batch number, date received, and expiration date on every storage unit.

• Keep Out of Reach of Unauthorized Personnel
  As Fasoracetam is strictly for research use only, it should be stored in a secure, access-controlled environment away from individuals not trained in laboratory safety protocols.

The research dosage of Fasoracetam can vary based on the purpose of the study, test subject species, and experimental design. Although it has been used in limited human trials, the compound remains unapproved for consumption, and all usage should be carefully calculated and monitored for safety in controlled settings.

• Microdosing in Cellular Studies
  In vitro experiments often use concentrations as low as 1–10 µM to observe molecular interactions, gene expression, or receptor activity in isolated cells.

• Rodent Models
  Animal studies commonly use 10–100 mg/kg depending on the goal—lower doses for cognitive enhancement studies and higher ones for mood or receptor response experiments.

• Human-Based Trials (Experimental Use Only)
  Clinical studies have used dosages between 50 mg and 200 mg orally per administration. However, these trials were under medical supervision and are not guidelines for general research use.

• Frequency of Dosing
  Fasoracetam’s short half-life (about 2–3 hours) means it may require multiple administrations per day in long-term research trials to maintain stable plasma levels.

• Accuracy in Measurement
  Precision is essential—use an accurate microgram scale and weigh each dose prior to solution preparation to avoid variability in testing outcomes.

• Choline Supplementation Consideration
  Many research protocols involve combining Fasoracetam with choline precursors (e.g., alpha-GPC) to reduce side effects and support cholinergic activity.

Yes, Fasoracetam is known for its water solubility, which makes it convenient for liquid-based research applications. Its chemical structure allows it to dissolve readily in both polar (water) and certain organic solvents, supporting a wide variety of experimental methodologies.

• Soluble in Distilled Water
  Fasoracetam can be fully dissolved in distilled water at room temperature, making it ideal for oral solution models and injection-based trials in rodents.

• Compatible with Ethanol and DMSO
  For experiments requiring organic solvents, Fasoracetam shows good solubility in ethanol and dimethyl sulfoxide (DMSO), commonly used in cellular and tissue-based research.

• Stability in Aqueous Solutions
  Once dissolved in water, Fasoracetam remains stable for several hours if stored at cool temperatures and shielded from light. However, it is recommended to prepare fresh solutions daily for accurate results.

• pH Consideration
  The compound dissolves best in neutral to slightly acidic pH environments. Highly alkaline conditions may degrade or alter the compound’s properties.

• Avoid Long-Term Pre-Mixing
  While stable in solution for short-term use, pre-mixed liquids stored for days may lose potency. Always mix shortly before use when possible.

• Use of Ultrasonic Bath (Optional)
  For precise solubilization in lab settings, an ultrasonic bath can be used to ensure even distribution of Fasoracetam in water without the need for heat.

In pharmacokinetic studies and experimental models, Fasoracetam displays a fast onset of action. This makes it particularly useful for acute behavioral testing or real-time neurotransmitter response observation. Its speed of effect also makes it distinct from slower-acting racetams that may require longer build-up periods.

• Onset in Animal Studies
  In rodents, behavioral changes have been observed within 30–45 minutes after oral or intraperitoneal administration. These include reductions in anxiety-related behavior and improved maze navigation.

• Human Trial Observations
  In limited human studies, Fasoracetam reportedly reached peak blood concentration within 1 to 2 hours, suggesting rapid absorption through the digestive tract.

• Short Half-Life Profile
  The compound is quickly eliminated, with a plasma half-life of approximately 2–3 hours. This rapid metabolism allows for clear experimental endpoints and minimizes carryover effects.

• Ideal for Short-Term Testing Models
  Because of its fast-acting nature, Fasoracetam is often used in single-session or short-cycle trials assessing acute cognition, focus, and neurotransmitter modulation.

• Rapid Blood-Brain Barrier Penetration
  Its lipophilic structure allows it to cross the blood-brain barrier efficiently, contributing to faster pharmacodynamic action in central nervous system studies.

• Minimal Accumulation
  The quick onset and elimination reduce the likelihood of buildup or compound stacking, making it safer and easier to dose repeatedly under experimental conditions.

Stacking refers to combining compounds to study synergistic effects or to minimize unwanted reactions. Fasoracetam is often stacked in research settings with cholinergic supplements or other racetams to investigate cognitive performance, neurotransmitter synergy, and receptor balancing. However, each stack should be designed with a clear hypothesis and safety considerations in place.

• Choline Precursors for Headache Prevention
  Alpha-GPC, CDP-Choline (Citicoline), or Centrophenoxine are commonly used in combination with Fasoracetam to offset choline depletion and enhance acetylcholine production.

• Stacking with Aniracetam or Noopept
  Some studies involve combining Fasoracetam with other racetams to evaluate layered cognitive responses, particularly in the areas of motivation, verbal fluidity, and memory consolidation.

• Combination with Adaptogens
  Fasoracetam is sometimes stacked with Rhodiola Rosea, Bacopa Monnieri, or L-Theanine to explore its interaction with stress-resistance pathways and long-term neuroplasticity.

• Neurotransmitter Modulator Stacks
  Due to its action on glutamate and GABA receptors, Fasoracetam may be stacked with other glutamatergic agents (e.g., Sunifiram) in advanced research models under controlled conditions.

• Dosage Adjustment Is Critical
  When stacking, each compound’s dosage must be adjusted to avoid overstimulation or receptor desensitization. Stacks must be carefully designed with respect to the pharmacokinetics of each compound.

• Stacking for ADHD Research
  In mGluR mutation-positive ADHD studies, Fasoracetam has been paired with other cognitive enhancers to assess complementary benefits in executive function and emotional control.

Fasoracetam does not appear to have a strong or direct influence on dopamine or serotonin systems, which distinguishes it from many other cognitive-enhancing or mood-modifying compounds. However, subtle interactions with monoaminergic pathways may occur indirectly through its action on GABA and glutamate regulation. These effects are of interest in psychiatric research, especially in studying mood and behavioral disorders that involve multiple neurotransmitter systems.

• Minimal Dopamine Receptor Binding
  Studies show Fasoracetam does not significantly bind to dopamine D1 or D2 receptors, indicating its psychoactivity is not dependent on the brain’s reward or pleasure systems.

• Increased Dopamine Turnover (Limited Context)
  In some animal studies, there is a mild uptick in dopamine turnover in the prefrontal cortex following administration. This suggests secondary modulation but not direct dopaminergic activation.

• No Serotonergic Agonism or Reuptake Inhibition
  Fasoracetam does not function as a serotonin reuptake inhibitor or receptor agonist. This means it does not produce typical SSRI-like effects and is less likely to disrupt serotonin balance.

• Low Risk of Dependency or Euphoria
  Since it lacks reinforcing effects on the dopamine system, Fasoracetam does not trigger addiction pathways, making it safer for repeated research trials involving behavior.

• May Influence Serotonin Indirectly via GABA
  GABAergic regulation can sometimes impact serotonin signaling downstream. While this is not a primary mechanism, Fasoracetam’s calming effects might modulate mood indirectly through GABA-5HT interplay.

• Stable Mood Profile
  In user-reported data and limited clinical studies, Fasoracetam has not been associated with mood swings, mania, or depression, further confirming its low serotonergic involvement.

Ensuring the authenticity of Fasoracetam is crucial for maintaining the reliability of your research results. With the increase in low-quality and mislabeled compounds in the market, it’s important to work with suppliers that provide transparency, third-party verification, and packaging that meets scientific standards. At RC Plug, we prioritize authenticity through multiple layers of quality control and accountability.

• Third-Party Laboratory Testing
  Every batch of Fasoracetam we ship is tested by an independent, ISO-certified laboratory using HPLC or GC-MS to confirm chemical identity and verify purity levels of ≥99%.

• Certificate of Analysis (COA)
  We provide a COA with every product batch, outlining key metrics such as molecular structure confirmation, purity percentage, CAS number validation, and production date.

• Tamper-Proof Packaging
  Our Fasoracetam is vacuum-sealed in odor-proof, UV-resistant, heat-sealed mylar pouches to maintain freshness and ensure no external contamination occurs.

• Batch Number and Traceability
  Each unit is labeled with a batch number that allows for traceability throughout the supply chain. This means we can verify when and where the compound was produced and tested.

• No Fillers, Additives, or Binders
  Our compound is sold in raw, uncut form with no bulking agents, preservatives, or additives. This ensures experimental reproducibility and accurate dosing in all test conditions.

• Full Refund or Replacement Guarantee
  If for any reason the product does not meet your expectations, we offer a 30-day money-back or product replacement policy. This ensures complete satisfaction with authenticity and quality.

Fasoracetam has not demonstrated addictive properties in any published animal or limited human research. Its lack of stimulant effect, euphoric response, or dopaminergic receptor binding contributes to a low potential for psychological or physiological dependence, making it a reliable candidate for repeated experimental use without high-risk modeling.

• Non-Reinforcing Behavior in Animal Studies
  In conditioned place preference (CPP) and self-administration studies, Fasoracetam has not led to compulsive or repetitive seeking behavior in rodents, unlike stimulants or opioids.

• No Dopamine Release Surge
  Addiction is often tied to substances that stimulate dopamine release in the brain’s reward centers. Fasoracetam does not trigger this pathway, drastically reducing abuse potential.

• No Withdrawal Symptoms Observed
  Research involving chronic administration does not report any form of withdrawal syndrome or post-discontinuation distress in test subjects.

• Calming, Not Stimulating
  Its primary effect is a subtle mood stabilization via GABAergic mechanisms rather than energetic stimulation, which tends to lower the risk of compulsive use behaviors.

• Not Scheduled or Controlled
  Its legal status reflects its low abuse potential, as it is not listed in any national or international controlled substance schedules.

• Safe for Repeated Use in Lab Models
  Fasoracetam has been administered daily in rodent and early human trials without signs of dosage escalation, loss of effect (tolerance), or physical dependence.

Fasoracetam is not included in standard drug screening panels such as those used for employment or athletics. Its unique chemical structure does not resemble that of stimulants, opioids, cannabinoids, or other common drug classes, making it undetectable unless specifically tested for in a research or forensic setting.

• Not Screened in Routine Panels
  Standard urine or saliva drug tests do not test for racetams, including Fasoracetam, due to their non-abusive pharmacological profile.

• Undetectable in DOT, SAMHSA, or 5-Panel Tests
  Fasoracetam is not listed in any major drug testing regulations for workplace or federal testing standards.

• No Cross-Reactivity
  The compound does not cross-react with amphetamines, benzodiazepines, or other drug categories, reducing the risk of false positives in any biological matrix.

• Detectable Only with Custom Testing
  Advanced laboratories could detect Fasoracetam through mass spectrometry or HPLC, but only if specifically instructed to target its chemical signature.

• Used in Clinical Trials, Not Illicit Contexts
  Fasoracetam’s profile as a research compound rather than a recreational drug means it is not typically subject to forensic interest or doping violations.

• Best Practice: Clear Labeling for Research Samples
  When handling Fasoracetam in institutional environments, researchers should label all materials appropriately to avoid confusion with prohibited substances.

Fasoracetam was originally developed in Japan as part of a pharmaceutical initiative aimed at treating vascular dementia. Although it did not reach full medical approval for that use, the compound showed enough promise in cognition and neurotransmitter studies that it attracted the attention of researchers worldwide. Its mechanism of action involving GABA and glutamate receptors makes it unique among racetams and has led to its broader use in modern nootropic and neuropsychiatric research.

• First Developed by Nippon Shinyaku
  Fasoracetam was synthesized and initially tested by Nippon Shinyaku, a Japanese pharmaceutical company, as part of a treatment pipeline for cognitive impairment.

• Originally Targeted Vascular Dementia
  Early research focused on elderly patients with cerebrovascular insufficiency, but clinical results were not strong enough to lead to mass approval for this indication.

• Acquired by Aevi Genomic Medicine
  The compound gained renewed interest when Aevi Genomic Medicine licensed the rights to study its use in children with ADHD linked to mGluR gene mutations.

• Inclusion in ADHD Trials
  Clinical trials for attention deficit disorders began in the mid-2010s, showing potential for symptom reduction in genetically susceptible populations.

• Growing Research Use Worldwide
  Fasoracetam has since gained traction among neuroscientists, psychopharmacologists, and biohackers for its fast-acting, low-toxicity profile and neurochemical versatility.

• Still Considered Investigational
  Despite multiple clinical trials, Fasoracetam remains a research chemical, not approved for general medicinal use by the FDA, EMA, or other major regulatory agencies.

Yes, Fasoracetam is available in bulk from RC Plug to support research institutions, academic labs, and large-scale testing operations. We offer volume-based pricing, custom packaging options, and guaranteed batch consistency to ensure you receive exactly what your research requires. Bulk purchasing is the ideal option for recurring studies or organizations conducting comparative testing across multiple variables.

• Tiered Discount Pricing
  Bulk orders come with reduced unit costs, making it cost-effective for organizations running high-frequency experiments or multi-subject trials.

• Consistent Batch Identity
  When ordering larger quantities, we ensure all units come from the same production batch, improving consistency and reducing variation between tests.

• Custom Packaging and Labeling
  We can accommodate special requests such as bulk vacuum-sealing, batch coding, or institutional labeling for efficient inventory management.

• Supply Chain Transparency
  Every bulk shipment is accompanied by a Certificate of Analysis (COA), batch number, and lab report to meet internal quality assurance protocols.

• Dedicated Account Support
  Bulk buyers receive priority service, including shipment tracking assistance, procurement documents, and tailored support for reorders.

• Safe and Compliant Transport
  Larger shipments are handled with extra care using tamper-proof, light-resistant materials and tracked logistics to ensure safety during transit.